Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
Clinical trial NCT04454905 · UNKNOWN
Trial details
- NCT number
- NCT04454905
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2024-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.